Shares of M.D.C. Holdings, Inc. (NYSE:MDC) have received a consensus recommendation of “Hold” from the nine ratings firms that are covering the company, Marketbeat.com reports. Two equities research analysts have rated the stock with a sell rating, one has assigned a hold rating and six have issued a buy rating on the company. The average 1-year price target among analysts that have updated their coverage on the stock in the last year is $34.00.

Several research analysts have issued reports on the stock. Zacks Investment Research cut shares of M.D.C. from a “hold” rating to a “sell” rating in a report on Tuesday, January 15th. ValuEngine upgraded shares of M.D.C. from a “sell” rating to a “hold” rating in a report on Wednesday, January 2nd.

NYSE MDC opened at $31.34 on Friday. The company has a current ratio of 9.15, a quick ratio of 2.49 and a debt-to-equity ratio of 0.70. The stock has a market capitalization of $1.92 billion, a PE ratio of 8.54, a P/E/G ratio of 1.16 and a beta of 1.33. M.D.C. has a 12 month low of $25.14 and a 12 month high of $33.47.

M.D.C. (NYSE:MDC) last posted its quarterly earnings results on Thursday, January 31st. The construction company reported $0.95 EPS for the quarter, missing the Zacks’ consensus estimate of $1.14 by ($0.19). The company had revenue of $858.49 million during the quarter, compared to the consensus estimate of $839.29 million. M.D.C. had a return on equity of 14.50% and a net margin of 6.93%. As a group, equities research analysts anticipate that M.D.C. will post 3.25 earnings per share for the current year.

In other M.D.C. news, COO David D. Mandarich sold 55,000 shares of the stock in a transaction dated Monday, February 25th. The shares were sold at an average price of $29.65, for a total transaction of $1,630,750.00. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director David Siegel sold 2,900 shares of the stock in a transaction dated Thursday, March 7th. The stock was sold at an average price of $28.18, for a total transaction of $81,722.00. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 194,089 shares of company stock worth $5,611,678. 26.30% of the stock is owned by company insiders.

Institutional investors have recently modified their holdings of the business. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in shares of M.D.C. by 25.8% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,326 shares of the construction company’s stock valued at $93,000 after buying an additional 683 shares during the last quarter. Bank of Montreal Can lifted its position in shares of M.D.C. by 14.1% during the fourth quarter. Bank of Montreal Can now owns 4,908 shares of the construction company’s stock valued at $138,000 after buying an additional 605 shares during the last quarter. Meeder Asset Management Inc. purchased a new stake in shares of M.D.C. during the fourth quarter valued at about $173,000. 6 Meridian purchased a new stake in shares of M.D.C. during the first quarter valued at about $207,000. Finally, Magnus Financial Group LLC purchased a new stake in shares of M.D.C. during the fourth quarter valued at about $208,000. Institutional investors own 84.61% of the company’s stock.

M.D.C. Company Profile

M.DC Holdings, Inc, through its subsidiaries, engages in the homebuilding and financial service businesses. Its homebuilding operations include purchasing finished lots or developing lots for the construction and sale primarily of single-family detached homes to first-time and first-time move-up homebuyers under the Richmond American Homes name.

Featured Article: How prevalent are 12b-1 fees?

Analyst Recommendations for M.D.C. (NYSE:MDC)

Receive News & Ratings for M.D.C. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for M.D.C. and related companies with MarketBeat.com's FREE daily email newsletter.